KELLY DUREN: Open Payments
NPI 1922036409 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| SHIELD THERAPEUTICS INC | 2 | $75 |
| Lilly USA, LLC | 4 | $74 |
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Dexcom, Inc. | 1 | $38 |
| Pulmonx Corporation | 1 | $26 |
Products named: ACCRUFER, MOUNJARO, ELIQUIS, AIRSUPRA, TRELEGY ELLIPTA, GEMTESA, Ozempic, Dexcom G6 Transmitter.
Industry payments across OK — which companies pay providers there.
